期刊文献+

甲状腺乳头状癌患者颈淋巴结转移的临床研究 被引量:5

A Clinic Study of Lymphatic Metastasis in Papillary Thyroid Carcinoma
下载PDF
导出
摘要 目的探讨甲状腺乳头状癌患者颈淋巴结转移的规律及清扫范围。方法回顾性分析笔者所在科室2010年1月~2011年1月初治的166例甲状腺乳头状癌患者的临床资料。研究患者性别、年龄、肿瘤大小和血清TSH与颈淋巴结转移率及转移范围的关系。采用χ2检验、t检验、Logistic模型及ROC曲线进行统计学分析。结果甲状腺乳头状癌淋巴结转移率为46.3%(77/166),年龄<45岁、肿瘤直径>0.5cm是颈淋巴结转移的独立危险因素(比值比分别为4.804和2.018,P均<0.05)。癌灶最大直径与颈部淋巴结转移相关的最佳临界点为0.55cm,敏感性和特异性分别为0.78和0.60,曲线下面积0.741(95%CI:0.667~0.815)。结论甲状腺乳头状癌患者肿瘤直径越大,淋巴结转移的可能就越大,且颈侧区淋巴结转移的可能性也越大,肿瘤直径可作为手术清扫范围的依据。 Objective To discuss the characters of the cervical lymph node metastasis of papillary thyroid carcinoma (PTC) and the extend of thyroidectomy and lymphadenectomy. Methods A total of 166 patients with PTC in our hospital from January 2010 to January 2011 were studied. The statistical correlation between possible factors associated with the presence of lymph node metastases (patients' age, sex,tumor size and TSH level) were analyzed with thex2 test,t test, Logistic regression analysis and receiver operating characteristic (ROC) curve analysis. Results The lymph node metastasis incidence was 46.3% (77/166). Age less than 45 and tumor diameter more than 0.5 cm were independent predictive factors for the lymph node metastasis ( odds ratio was 4. 804 and 2.018, P 〈 0.05, respectively). The optimal cut - off point which evaluated the tumor diameter as a predictor for lymph node metastasis is 0.55cm with the best sensitivity and specificity (0.78 and 0.60, respectively) and the area under ROC was 0. 741 (95% CI:0. 667 -0. 815). Conclusion The larger of the tumor size a PTC patient gets, the more possibility of cervical lymph node metastasis will occur. Therefore, the tumor size can be used to determine the extend of thyroidectomy and lymphadenectomy.
作者 李琛 罗定存
出处 《医学研究杂志》 2012年第7期169-171,61,共4页 Journal of Medical Research
关键词 甲状腺肿瘤 甲状腺乳头状癌 淋巴转移 颈淋巴结清扫 血清TSH Thyroid neoplasms Papillary thyroid carcinoma (PTC) Lymphatic metastasis Radical neck dissection TSH
  • 相关文献

参考文献13

  • 1向俊,吴毅.甲状腺癌临床诊治新特点(附572例临床分析)[J].中国实用外科杂志,2008,28(5):365-367. 被引量:107
  • 2郑泽霖,孙辉,盖宝东.甲状腺疾病外科治疗的热点和难点[J].中国普外基础与临床杂志,2008,15(5):307-310. 被引量:40
  • 3Mazzaferri EL, Massol N. Management of papillary and follicular ( dif- ferentiated) thyroid cancer: new paradigms using recombinant human thyrotorpin [ J ]. Endocr Relat Cancer,2002,9 (4) :227 - 247.
  • 4Gardner RE, Tuttle RM, Bunnan KD, et al. Prognostic importance of vascular invasion in papillary thyroid carcinoma[J].Arch Otolaryngol Head Neck Surg,2000,126 ( 3 ) :309 - 312.
  • 5Sebastian SO, Gonzalez JM, Paricio PP, et al. Papillary thyroid carcinoma:prognostic index for survival including the histological variety [ J ]. Arch Surg,2000,135(3) :272 -277.
  • 6任国胜,苏新良.分化型甲状腺癌颈淋巴结清扫术式的选择[J].中国普外基础与临床杂志,2010,17(8):765-767. 被引量:22
  • 7Noguchi M, Kumaki T, Taniya T, et al. Bilateral cervical lymph node metastases in well - differentiated thyroid cancer [J]. Arch Surg, 1990,125 (6) :804 - 806.
  • 8Simon D, Goretzki PE ,Witte J,et al. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma [ J ]. World J Surg, 1996,20 ( 7 ) : 860 - 866.
  • 9Miralie E, Visset J, Sagan C, et al. Localization of cervical node me- tastasis of papillary thyroid carcinoma [ J] .World J Surg, 1999, 23 (9) :970 -974.
  • 10Koo BS, Choi EC, Yoon YH, et al. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma [ J ]. Ann Stag, 2009,249 ( 5 ) : 840 - 844.

二级参考文献36

共引文献157

同被引文献51

  • 1贺伟,曹苏生,王伟,李昌文.中央组淋巴结清除术治疗cN_0期分化型甲状腺癌的初步临床观察[J].中华肿瘤防治杂志,2008,15(24):1903-1904. 被引量:4
  • 2孙建光,胡浩忠,戴亚伟,陶国卫,张芸.cN_0甲状腺乳头状癌74例治疗分析[J].中国癌症杂志,2011,21(4):294-297. 被引量:13
  • 3孙向东,杨秀荣.甲状腺乳头状癌经淋巴结转移规律及治疗策略[J].河南肿瘤学杂志,2004,17(5):336-337. 被引量:21
  • 4石岚,黄韬.甲状腺乳头状癌淋巴结转移规律的研究[J].中华普通外科杂志,2007,22(7):524-526. 被引量:53
  • 5Schweizer I, Seifert B, C, emsenjager g. Which lymphadenectomy in papillary thyroid gland carcinoma. Swiss Surg,2003,9(2) :63- 68.
  • 6R. Arem, S. Padayatti, A. H. Saliby, and S. I. Sherman, prevalence, prognosis, and management, "Thyroid Endocrine Practise, 1999, 5: 148-156.
  • 7Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid micmcarcinomas: frequency, pattern of occurrence,and optimal strategy for neck dissection. Annals of Surgery, 2003, 237:399-407.
  • 8Sacco R, Aversa S, lnnaro N, et al. Thyroid multinodular stnmaa, personal experience and considerations regarding surgical therapy. Chimrgia Italiana,2006,58: 69-75.
  • 9Chow SM, Law SCK, Chan JKC, et al. Papillarymicrocarcinoma of the thyroid prognostic significance of lymph node metastasis and multifocality. Cancer, 2003:98:31-40.
  • 10Bo-Yeon Kim, Chan-Hee Jung, Jae-Wook Kim, et al. Impact of clinicopathologic factor on subclinical central lymph node metast,xfis in papillary thyroid microcarcinoma. Yonsei MedJ,2012,53(5): 924-930.

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部